We are live on ! Find out more
IOVA icon

Iovance Biotherapeutics

249 hedge funds and large institutions have $2.6B invested in Iovance Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 109 increasing their positions, 66 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

458% more call options, than puts

Call options by funds: $41.7M | Put options by funds: $7.48M

65% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 66

18% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 39

1% more funds holding

Funds holding: 246249 (+3)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.16% less ownership

Funds ownership: 99.36%99.21% (-0.16%)

12% less capital invested

Capital invested by funds: $2.96B → $2.6B (-$366M)

Holders
249
Holders Change
+3
Holders Change %
+1.22%
% of All Funds
3.93%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
46
Increased
109
Reduced
66
Closed
39
Calls
$41.7M
Puts
$7.48M
Net Calls
+$34.2M
Net Calls Change
-$24.4M